ArticleBritish journal of pharmacology2016

Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing.

Can-Can Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.